GLOBAL NEWS
REUTERS
THE NEW YORK TIMES
YAHOO
INDIA BUSINESS
BUSINESS STANDARD
BUSINESS TODAY
ECONOMIC TIMES
MONEYCONTROL
THE HINDU
INDIA COMMODITIES
ECONOMIC TIMES
MONEYCONTROL
INDIA CURRENCY
ECONOMIC TIMES
MONEYCONTROL
INDIA MARKET
BUSINESS INSIDER
BUSINESS STANDARD
BUSINESS TODAY
ECONOMIC TIMES
MONEYCONTROL
NDTV
NSE
THE FINANCIAL EXPRESS
THE HINDU
INDIA MUTUAL FUNDS
BUSINESS STANDARD
ECONOMIC TIMES
INDIA MUTUAL FUNDS BLOGS
FUNDSINDIA
INDIA NEWS
BUSINESS STANDARD
ECONOMIC TIMES
FIRSTPOST
MONEYCONTROL
REUTERS
THE FINANCIAL EXPRESS
THE HINDU
YAHOO
 Save

INDIA MARKET | Mon, 16 Nov 2026, 10:15PM IST Germany will host Group A2 leaders Netherlands in their final league-phase fixture of the 2026-27 UEFA Nations League campaign.

Continue reading at NDTV

1m

INDIA MARKET | Mon, 16 Nov 2026, 2:23PM IST Amber Enterprises rallied over 9% in Friday's trade after reporting Q2 earnings. Analysts at Elara Securities and Equirus expect margin pressure to persist in Q2FY27.

Continue reading at Business Standard

19m

INDIA MARKET | Mon, 16 Nov 2026, 2:23PM IST Stock Market Today, November 16

Continue reading at NDTV

20m

INDIA MARKET | Mon, 16 Nov 2026, 2:16PM IST Anirudh made a name for himself with Why This Kolaveri Di from the 2012 film 3.

Continue reading at NDTV

26m

INDIA BUSINESS | Mon, 16 Nov 2026, 2:13PM IST Tata Steel expects to perform significantly better in the second half of the current fiscal than in the first six months, CEO and Managing Director TV Narendran said. He said steel demand remains strong and market conditions are favourable, while growth in key customer segments such as automobiles and construction has also been encouraging, helping the company post a reasonably good performance in the first half. However, the conflict in West Asia has had an impact of around Rs 1,000 crore per quarter on the company and about Rs 1,400 crore globally, Narendran said during an interaction with the press on the sidelines of the inauguration of the five-day pan-India tribal conclave 'Samvaad' in Jamshedpur on Sunday. He acknowledged operational challenges at the company's Kalinganagar and Meramandali plants in Odisha during the first half, but expressed confidence that production and operations would stabilise in the second half. On expansion plans, Narendran said Tata Steel had announ

Continue reading at Business Standard

30m

INDIA BUSINESS | Mon, 16 Nov 2026, 2:11PM IST Jimmy Tata, the younger brother of Ratan Tata and a trustee of Tata Trusts, has backed the listing of Tata Sons, raising concerns over the powers of its chairman Noel Tata

Continue reading at Business Standard

31m

INDIA MARKET | Mon, 16 Nov 2026, 2:11PM IST Sensex Today | Stock Market LIVE Updates Monday:In the broader market, the Nifty MidCap 100 and the Nifty SmallCap 100 fell 0.41 per cent and 0.78 per cent, respectively

Continue reading at Business Standard

31m

INDIA MARKET | Mon, 16 Nov 2026, 2:11PM IST Inox Wind reported a 42 per cent decline in its consolidated net profit to 69 crore in the September quarter due to higher expenses.

Continue reading at Business Standard

31m

INDIA MARKET | Mon, 16 Nov 2026, 2:07PM IST You must compare bank rates, tenure, and premature withdrawal penalties.

Continue reading at NDTV

35m

INDIA BUSINESS | Mon, 16 Nov 2026, 2:02PM IST Real estate investments broaden across asset classes in APAC; India sees 6X surge in 2026 hospitality investments: Colliers India

Continue reading at Business Standard

40m

INDIA MARKET | Mon, 16 Nov 2026, 2:02PM IST Samir Arora On AI, Nvidia, FIIs and Oil

Continue reading at NDTV

41m

INDIA NEWS | Mon, 16 Nov 2026, 1:59PM IST The policy is a targeted farm-development scheme rather than a general incentive framework for every poultry-related enterprise

Continue reading at Business Standard

44m

INDIA MARKET | Mon, 16 Nov 2026, 1:57PM IST TVS Family Rift In Focus

Continue reading at NDTV

45m

INDIA BUSINESS | Mon, 16 Nov 2026, 1:57PM IST Non-banking finance company Muthoot FinCorp Ltd has reported a two-fold jump in profit after tax to Rs 779 crore in the September quarter, driven by enhanced asset quality. The company's profit after tax stood at Rs 388 crore in the July-September quarter of FY26. Total income rose 71 per cent year-on-year to Rs 3,408 crore in the second quarter of FY27 from Rs 1,997 crore, Muthoot FinCorp, part of the Muthoot Pappachan Group, said in a regulatory filing. On a sequential basis, Muthoot FinCorp's profit after tax rose 10.5 per cent from Rs 705 crore in the preceding June quarter, while total income increased 7.9 per cent from Rs 3,159 crore. Asset quality also improved, with Stage III loan assets as a proportion of gross loan assets declining to 1.07 per cent as of September 2026 from 1.41 per cent year-earlier. Net Stage III loan assets fell to 0.63 per cent from 0.76 per cent. For the six months ended September 2026, the company's PAT rose to Rs 1,485 crore from Rs 568 crore in H

Continue reading at Business Standard

45m

INDIA BUSINESS | Mon, 16 Nov 2026, 1:57PM IST IBM spends about USD 3 billion annually in India and plans to invest USD 10 billion globally in quantum computing over the next five years, Chairman and Chief Executive Arvind Krishna said, underlining the technology major's long-term commitment to the country even as he flagged significant disruption to employment from artificial intelligence. AI could displace 10-20 per cent of jobs over the next decade, with the business process outsourcing (BPO) industry likely to face some of the biggest reductions in employment, Krishna said, arguing that businesses and governments would need to prepare workers for changes in the nature of work. "Whenever these happen, there is some level of displacement. I think we should face up to that," he said during an interaction with journalists. The impact, however, would unfold over a decade rather than within a year, he said, adding that society needed to consider how to help workers adapt to the transition. "If I was to tell you the part, I think

Continue reading at Business Standard

46m

INDIA MARKET | Mon, 16 Nov 2026, 1:55PM IST Cyclone Akvan is expected to form over the central Bay of Bengal on November 16.

Continue reading at NDTV

47m

INDIA MARKET | Mon, 16 Nov 2026, 1:46PM IST Competition between the US and China is another factor influencing investment decisions.

Continue reading at NDTV

56m

INDIA MARKET | Mon, 16 Nov 2026, 1:41PM IST The IAF is expected to induct its first full squadron of indigenous Tejas Mark 1A fighter jets by the end of the current financial year, Air Chief Marshal Ashutosh Dixit said.

Continue reading at NDTV

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:40PM IST Prince William and Princess Kate enjoy gully cricket during three-day India trip.

Continue reading at NDTV

1h

INDIA BUSINESS | Mon, 16 Nov 2026, 1:39PM IST Biocon Ltd has announced receiving US FDA approval for their biosimilar Pebrilzo, which treats HER2-positive breast cancer. This milestone adds to Biocon's portfolio, increasing their number of oncology biosimilars approved in the United States to five. The company has also secured a global settlement with Genentech for Pebrilzo's earliest licensed launch date in 2028.

Continue reading at Economic Times

1h

INDIA NEWS | Mon, 16 Nov 2026, 1:39PM IST New Delhi: Biopharmaceutical company Biocon Ltd on Monday said it has received approval from the US Food and Drug Administration (FDA) for Pebrilzo (pertuzumab-qcay) injection, a biosimilar to Perjeta, used in the treatment of HER2-positive breast cancer.Pebrilzo is a monoclonal antibody that treats HER2-positive breast cancer by blocking HER2 receptors on cancer cells. With this approval, Biocon now has five oncology biosimilar therapies approved in the United States, the company said in a regulatory filing.Biocon has also entered into a global settlement and licence agreement with Genentech, securing the earliest licensed launch date for Pebrilzo in the US in the third quarter of calendar year 2028."The US FDA approval of PEBRILZO, our biosimilar pertuzumab, marks another significant milestone in Biocon's journey to expand access to high-quality biosimilars," said Shreehas Tambe, CEO & Managing Director, Biocon Limited.He added that the approval strengthens the company's anti-cancer portfolio and advances its commitment to expanding access to high-quality, affordable biologic medicines for patients facing both physical and financial burdens from the disease.Pebrilzo joins Biocon's existing US oncology portfolio, which includes Ogivri (trastuzumab-dkst), Jobevne (bevacizumab-nwgd), Fulphila (pegfilgrastim-jmdb), and Aukelso (denosumab-kyqq), the filing said.Earlier in September, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion recommending marketing authorisation for Biocon's pertuzumab biosimilar under the brand name Pebrilzo in Europe.According to the company, approximately 320,000 women in the US may be diagnosed with breast cancer in 2026, of whom about 20 per cent will be HER2-positive.

Continue reading at Economic Times

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:39PM IST Morgan Stanley sees 2027 to be a "turning point" for Indian equities.

Continue reading at NDTV

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:32PM IST Jefferies said that Patanjali Foods' Q2 miss was driven by a shift in festive-season timing and edible-oil margin pressure from the import duty cut.

Continue reading at Business Standard

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:23PM IST Share price of Max Healthcare soared 7% to 1,007.70 on the BSE in Monday's intraday trade, bouncing back 26% from its 52-week low of 797 touched on October 22, 2026.

Continue reading at Business Standard

1h

INDIA NEWS | Mon, 16 Nov 2026, 1:21PM IST Fuel and power inflation surged to 32.84% in October, driving wholesale inflation to a series high of 12.29%, even as price pressures in manufactured products eased

Continue reading at Business Standard

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:16PM IST On Chandrasekaran, Jimmy credited the chairman with turning around heavily indebted Tata companies, delivering record earnings and dividends exceeding 6,500%.

Continue reading at NDTV

1h

INDIA BUSINESS | Mon, 16 Nov 2026, 1:05PM IST The November 2018 gold bond tranche matures at Rs 14,024 per gram, apart from eight years of fixed interest income

Continue reading at Business Standard

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:05PM IST The Supreme Court has upheld the NCLAT's decision to send Twinstar Technologies' 2,962-crore Videocon resolution plan back to lenders, citing concerns over creditor payouts and statutory compliance

Continue reading at Business Standard

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:04PM IST Here's a look at how the three films performed at the box office.

Continue reading at NDTV

1h

INDIA BUSINESS | Mon, 16 Nov 2026, 1:02PM IST A spouse faces no income ceiling, but other family members must meet specific earnings and dependency criteria to claim benefits

Continue reading at Business Standard

1h

INDIA MARKET | Mon, 16 Nov 2026, 1:02PM IST Stock Market Today, November 16

Continue reading at NDTV

1h

INDIA BUSINESS | Mon, 16 Nov 2026, 12:57PM IST Mahanadi Coalfields, Coal India's largest coal-producing subsidiary, is set to enter the stock market through an offer for sale of a 10% stake

Continue reading at Business Standard

1h

INDIA MARKET | Mon, 16 Nov 2026, 12:57PM IST Finance Minister Chairs The First Pre-Budget Consultation With Economists

Continue reading at NDTV

1h

INDIA MARKET | Mon, 16 Nov 2026, 12:43PM IST Varun Dhawan injures wrist during water skiing.

Continue reading at NDTV

1h

INDIA MARKET | Mon, 16 Nov 2026, 12:41PM IST The company has appointed Mohammed Turra as Additional Director and MD & CEO-designate, effective November 16.

Continue reading at Business Standard

2h

INDIA MARKET | Mon, 16 Nov 2026, 12:41PM IST The All Commodities Index rose to 113.3 in October from 112.5 in September 2026.

Continue reading at NDTV

2h

INDIA BUSINESS | Mon, 16 Nov 2026, 12:36PM IST Glenmark Pharmaceuticals Inc has announced the launch of Axitinib Tablets in the United States in two strengths. These tablets are a generic version of Pfizer's Inlyta, used for advanced renal cell carcinoma treatment. The introduction of this product reflects Glenmark's ongoing commitment to providing affordable medicines to patients. Annual sales of Inlyta tablets reached approximately USD 538.4 million in the US during the last year.

Continue reading at Economic Times

2h

INDIA MARKET | Mon, 16 Nov 2026, 12:33PM IST Despite his demanding professional responsibilities, Huang personally stepped in to help the family navigate the crisis, said woman.

Continue reading at NDTV

2h

INDIA MARKET | Mon, 16 Nov 2026, 12:32PM IST Downfall of the devil's metal.

Continue reading at NDTV

2h

INDIA NEWS | Mon, 16 Nov 2026, 12:26PM IST India's wholesale inflation quickened to 12.29% year-on-year in October, from 11.39% in September, official data released on Monday showed.The All India Wholesale Price Index (WPI) for all commodities stood at 113.3 in October, compared with 112.5 in the previous month.Among major groups, inflation in fuel and power accelerated sharply to 32.84% in October, from 25.85% in September. Inflation in primary articles rose to 9.24% from 8.67%, while that in manufactured products eased marginally to 9.54% from 9.76%.The increase in wholesale inflation was driven by mineral oils, crude petroleum and natural gas, electricity, food articles, basic metals, chemicals, food products, non-food articles, textiles, and rubber and plastic products.Food inflation eases marginally to 8.58%Inflation in the WPI Food Index eased marginally to 8.58% in October from 8.66% in September. The index comprises food articles under primary articles and manufactured food products.Retail inflation breaches RBI's 6% upper tolerance limitRetail inflation, meanwhile, surged to 6.09% year-on-year in October, crossing the Reserve Bank of India's upper tolerance limit for the first time under the new consumer price index (CPI) series.The uptick has heightened inflation concerns and fuelled expectations of a 25-basis-point repo rate hike at the RBI's December monetary policy meeting. One basis point is equal to a hundredth of a percentage point.Inflation has now remained above the RBI's medium-term target of 4% for five consecutive months. The central bank allows a tolerance band of two percentage points on either side of this target. The last time retail inflation breached the 6% upper limit was in October 2024, when it stood at 6.2% under the previous CPI series, which had 2012 as its base year.

Continue reading at Economic Times

2h

INDIA BUSINESS | Mon, 16 Nov 2026, 12:23PM IST Glenmark Pharmaceuticals Inc, USA, on Monday announced the launch of Axitinib Tablets in 1 mg and 5 mg strengths, a generic version of Pfizer Inc's Inlyta tablets. Glenmark Axitinib tablets (a generic equivalent to Pfizer's Inlyta) are used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer. "The launch of Axitinib tablets reinforces Glenmark's commitment to expanding access to quality, affordable medicines for patients in the United States," said Marc Kikuchi, President & Business Head, North America. By adding this product to its portfolio, the company continues to strengthen focus on addressing the evolving needs of patients and healthcare providers, he said . According to IQVIA sales data for the 12-month period ended September 2026, annual sales of Inlyta tablets in the US were around USD 538.4 million, the company said in a statement.

Continue reading at Business Standard

2h

INDIA MARKET | Mon, 16 Nov 2026, 12:22PM IST India's wholesale inflation rose to 12.29 per cent in October from 11.39 per cent in September, driven by fuel and power, primary articles and manufactured products

Continue reading at Business Standard

2h
more